Knight Therapeutics Inc. 13D and 13G filings for 60 Degrees Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-29 4:06 pm Purchase | 2026-07-22 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Knight Therapeutics Inc. | 658,629 19.850% | 658,629 (New Position) | Filing |
| 2026-05-15 4:02 pm Sale | 2026-03-31 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Knight Therapeutics Inc. | 0 0.000% | -8,475 (Position Closed) | Filing |
| 2024-11-13 4:01 pm Purchase | 2024-09-30 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Knight Therapeutics Inc. | 8,475 9.100% | 8,475 (New Position) | Filing |